IRadimed Corporation (IRMD)
USD 49.54
(-3.54%)
USD 49.54
(-3.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 17.19 Million USD | 34.02% |
| 2022 | 12.82 Million USD | 37.56% |
| 2021 | 9.32 Million USD | 581.19% |
| 2020 | 1.36 Million USD | -85.79% |
| 2019 | 9.63 Million USD | 52.79% |
| 2018 | 6.3 Million USD | 1161.29% |
| 2017 | 499.76 Thousand USD | -93.07% |
| 2016 | 7.21 Million USD | -4.19% |
| 2015 | 7.52 Million USD | 267.25% |
| 2014 | 2.05 Million USD | 5.86% |
| 2013 | 1.93 Million USD | 100.49% |
| 2012 | 966.08 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.9 Million USD | 18.49% |
| 2024 Q1 | 4.13 Million USD | -8.88% |
| 2024 Q3 | 5.04 Million USD | 3.03% |
| 2023 Q2 | 4.17 Million USD | 22.72% |
| 2023 FY | 17.19 Million USD | 34.02% |
| 2023 Q1 | 3.4 Million USD | -7.28% |
| 2023 Q4 | 4.53 Million USD | -10.41% |
| 2023 Q3 | 5.06 Million USD | 21.23% |
| 2022 Q2 | 3.24 Million USD | 30.33% |
| 2022 Q1 | 2.48 Million USD | -36.12% |
| 2022 FY | 12.82 Million USD | 37.56% |
| 2022 Q4 | 3.67 Million USD | 7.19% |
| 2022 Q3 | 3.42 Million USD | 5.74% |
| 2021 Q1 | 1.38 Million USD | 117.57% |
| 2021 Q2 | 1.46 Million USD | 5.97% |
| 2021 FY | 9.32 Million USD | 581.19% |
| 2021 Q3 | 2.57 Million USD | 75.29% |
| 2021 Q4 | 3.89 Million USD | 51.1% |
| 2020 Q3 | 1.07 Million USD | 150.88% |
| 2020 Q4 | 637.41 Thousand USD | -40.69% |
| 2020 FY | 1.36 Million USD | -85.79% |
| 2020 Q1 | 1.76 Million USD | -45.42% |
| 2020 Q2 | -2.11 Million USD | -219.39% |
| 2019 FY | 9.63 Million USD | 52.79% |
| 2019 Q1 | 1.84 Million USD | 8.12% |
| 2019 Q4 | 3.24 Million USD | 32.05% |
| 2019 Q3 | 2.45 Million USD | 17.52% |
| 2019 Q2 | 2.08 Million USD | 13.18% |
| 2018 Q4 | 1.7 Million USD | -28.88% |
| 2018 Q2 | 1.35 Million USD | 61.08% |
| 2018 Q1 | 841.19 Thousand USD | 358.07% |
| 2018 FY | 6.3 Million USD | 1161.29% |
| 2018 Q3 | 2.4 Million USD | 77.15% |
| 2017 Q2 | 357.07 Thousand USD | 253.03% |
| 2017 Q4 | 183.63 Thousand USD | -4.55% |
| 2017 FY | 499.76 Thousand USD | -93.07% |
| 2017 Q1 | -233.34 Thousand USD | -120.45% |
| 2017 Q3 | 192.39 Thousand USD | -46.12% |
| 2016 Q1 | 2.28 Million USD | -5.1% |
| 2016 FY | 7.21 Million USD | -4.19% |
| 2016 Q4 | 1.14 Million USD | -26.89% |
| 2016 Q3 | 1.56 Million USD | -30.06% |
| 2016 Q2 | 2.23 Million USD | -2.22% |
| 2015 Q3 | 1.86 Million USD | 5.45% |
| 2015 Q2 | 1.77 Million USD | 19.03% |
| 2015 Q1 | 1.48 Million USD | 449.25% |
| 2015 FY | 7.52 Million USD | 267.25% |
| 2015 Q4 | 2.4 Million USD | 28.79% |
| 2014 FY | 2.05 Million USD | 5.86% |
| 2014 Q4 | 270.82 Thousand USD | 14.1% |
| 2014 Q1 | 523.36 Thousand USD | 10.42% |
| 2014 Q2 | 1.01 Million USD | 94.67% |
| 2014 Q3 | 237.35 Thousand USD | -76.7% |
| 2013 FY | 1.93 Million USD | 100.49% |
| 2013 Q2 | 558.3 Thousand USD | -13.3% |
| 2013 Q4 | 473.98 Thousand USD | 81.83% |
| 2013 Q3 | 260.67 Thousand USD | -53.31% |
| 2013 Q1 | 643.92 Thousand USD | 0.0% |
| 2012 FY | 966.08 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 127.902% |
| BrainsWay Ltd. | -4.19 Million USD | 509.644% |
| Cerus Corporation | -37.48 Million USD | 145.861% |
| Envoy Medical, Inc. | -29.9 Million USD | 157.486% |
| electroCore, Inc. | -18.83 Million USD | 191.286% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 294.269% |
| IceCure Medical Ltd | -14.65 Million USD | 217.341% |
| Inogen, Inc. | -102.44 Million USD | 116.782% |
| OrthoPediatrics Corp. | -20.97 Million USD | 181.972% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 132.645% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 225.082% |
| MaxCyte, Inc. | -37.92 Million USD | 145.336% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 244.971% |
| Nexalin Technology, Inc. | -4.64 Million USD | 469.84% |
| Orthofix Medical Inc. | -151.39 Million USD | 111.356% |
| PAVmed Inc | -64.17 Million USD | 126.79% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 132.769% |
| RxSight, Inc. | -48.6 Million USD | 135.37% |
| Sight Sciences, Inc. | -55.54 Million USD | 130.952% |
| SI-BONE, Inc. | -43.33 Million USD | 139.673% |
| TELA Bio, Inc. | -46.66 Million USD | 136.844% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 134.714% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 226.576% |
| Acutus Medical, Inc. | -81.66 Million USD | 121.053% |
| Talis Biomedical Corporation | -62 Million USD | 127.727% |
| Spectral AI, Inc. | -20.85 Million USD | 182.444% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 128.289% |
| CVRx, Inc. | -41.19 Million USD | 141.731% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -2585.549% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 256.936% |
| Bioventus Inc. | -156.23 Million USD | 111.005% |
| Venus Concept Inc. | -37.25 Million USD | 146.155% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 129.122% |
| LivaNova PLC | 17.54 Million USD | 2.013% |
| 908 Devices Inc. | -36.39 Million USD | 147.234% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 109.212% |
| Nemaura Medical Inc. | -14.14 Million USD | 221.558% |
| NeuroPace, Inc. | -32.95 Million USD | 152.169% |
| LENSAR, Inc. | -14.38 Million USD | 219.535% |
| Apyx Medical Corporation | -18.71 Million USD | 191.876% |
| Cutera, Inc. | -162.83 Million USD | 110.559% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 258.751% |
| BioSig Technologies, Inc. | -29.04 Million USD | 159.202% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 120.798% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 177.834% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 74.62% |
| Axonics, Inc. | -6.08 Million USD | 382.404% |
| Outset Medical, Inc. | -172.79 Million USD | 109.95% |
| IRIDEX Corporation | -9.57 Million USD | 279.653% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 116.235% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 308.549% |
| INVO Bioscience, Inc. | -8.03 Million USD | 313.984% |
| Telesis Bio, Inc. | -47.72 Million USD | 136.025% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -67.849% |
| Varex Imaging Corporation | -47.7 Million USD | 136.044% |
| Quipt Home Medical Corp. | -2.78 Million USD | 717.557% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 252.337% |
| Pulmonx Corporation | -60.84 Million USD | 128.258% |
| Dynatronics Corporation | -2.69 Million USD | 737.308% |
| Modular Medical, Inc. | -17.47 Million USD | 198.413% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 250.986% |
| Semler Scientific, Inc. | 20.58 Million USD | 16.471% |
| InMode Ltd. | 197.91 Million USD | 91.313% |
| Bruker Corporation | 427.2 Million USD | 95.975% |
| Cytosorbents Corporation | -28.5 Million USD | 160.31% |
| DexCom, Inc. | 541.5 Million USD | 96.825% |
| Align Technology, Inc. | 445.05 Million USD | 96.137% |
| Viveve Medical, Inc. | -22.02 Million USD | 178.053% |
| ZimVie Inc. | -393.28 Million USD | 104.372% |
| Movano Inc. | -29.28 Million USD | 158.712% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 241.528% |
| Nexalin Technology, Inc. | -4.64 Million USD | 469.84% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -2585.549% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 107.723% |
| Profound Medical Corp. | -28.56 Million USD | 160.18% |
| Insulet Corporation | 206.3 Million USD | 91.666% |
| enVVeno Medical Corporation | -23.51 Million USD | 173.111% |
| Surmodics, Inc. | -11.54 Million USD | 248.958% |
| iCAD, Inc. | -4.84 Million USD | 454.71% |
| Nuwellis, Inc. | -20.2 Million USD | 185.075% |
| Biotricity, Inc. | -14.09 Million USD | 221.984% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 113.932% |
| Aethlon Medical, Inc. | -12.2 Million USD | 240.83% |
| InspireMD, Inc. | -19.91 Million USD | 186.326% |
| PAVmed Inc. | -64.17 Million USD | 126.79% |
| BIOLASE, Inc. | -20.63 Million USD | 183.331% |
| Beyond Air, Inc. | -60.24 Million USD | 128.54% |
| FONAR Corporation | 10.56 Million USD | -62.696% |
| AxoGen, Inc. | -21.71 Million USD | 179.171% |
| Vivani Medical, Inc. | -25.65 Million USD | 167.023% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 39.706% |
| Inari Medical, Inc. | -1.63 Million USD | 1150.903% |
| UFP Technologies, Inc. | 44.92 Million USD | 61.729% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 434.99% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 360.291% |
| Tenon Medical, Inc. | -15.58 Million USD | 210.344% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 211.453% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 148.659% |
| AdaptHealth Corp. | -678.89 Million USD | 102.532% |
| Sintx Technologies, Inc. | -8.25 Million USD | 308.17% |
| NanoVibronix, Inc. | -3.71 Million USD | 563.292% |
| Quanterix Corporation | -32.33 Million USD | 153.172% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 252.337% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -3444.902% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 105.605% |
| TransMedics Group, Inc. | -25.02 Million USD | 168.694% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 177.679% |
| NeuroMetrix, Inc. | -6.52 Million USD | 363.31% |
| Hyperfine, Inc. | -44.23 Million USD | 138.864% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 121.901% |
| Biomerica, Inc. | -5.97 Million USD | 387.601% |
| Bone Biologics Corporation | -8.94 Million USD | 292.125% |
| AVITA Medical, Inc. | -39.16 Million USD | 143.895% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 272.724% |
| Silk Road Medical, Inc | -55.74 Million USD | 130.843% |